Related Experiment Video
Updated: Apr 22, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Squamous cell carcinoma and eosinophilia in a long-term course of pansclerotic morphea
Inderjote Grewal1, Omar Khan2, William Davis2
1University of Queensland, Brisbane, Queensland, Australia.
Abstract:
Pansclerotic morphea is a rare subtype of localised scleroderma. Very few cases have been reported in the literature. This case discusses a young man with a 15-year history of pansclerotic morphea, illustrating the clinical course and complications of this disease. Notably, recurrent squamous cell carcinomas with several high-risk features and frequent cellulitis were the basis of many admissions. As often seen with this disease, autoimmune markers were negative. However, marked eosinophilia was noted late in the course. Furthermore, this disease is quite resistant to treatment. Immunosuppressive therapy thus far has perhaps slowed the progression, although not cured the disease in this patient.
Insights
Pansclerotic morphea, a rare scleroderma subtype, presents significant challenges. This case highlights its chronic course, complications like skin cancer, and resistance to treatment.
Area of Science:
- Dermatology
- Rheumatology
- Rare Diseases
Background:
- Pansclerotic morphea is an exceptionally rare subtype of localized scleroderma, with limited documented cases.
- Understanding its long-term clinical course and potential complications is crucial for patient management.
Observation:
- A young male patient with a 15-year history of pansclerotic morphea is presented.
- The patient experienced recurrent squamous cell carcinomas with high-risk features and frequent cellulitis, necessitating numerous hospital admissions.
- Autoimmune markers were negative, but marked eosinophilia was observed later in the disease progression.
Findings:
- Pansclerotic morphea demonstrates a challenging clinical course with severe complications, including malignancy.
- The disease is characterized by resistance to conventional treatments.
- Immunosuppressive therapy showed potential in slowing progression but did not achieve a cure.
Implications:
- This case underscores the need for vigilant monitoring for complications such as squamous cell carcinoma in pansclerotic morphea patients.
- Further research into effective treatment strategies for this rare and aggressive condition is warranted.
- The findings suggest a complex pathophysiology, potentially involving factors beyond typical autoimmune markers.
Related Concept Videos
Chronic Obstructive Pulmonary Disease II: Emphysema
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Cellular Adaptation IV: Dysplasia and Metaplasia
Esophageal Achalasia

